SPY331.68+1.62 0.49%
DIA271.29+2.88 1.07%
IXIC10,976.01+34.84 0.32%

EU's CHMP Gives Positive Opinion For Novartis' Mayzent For Adult Patients With Secondary Progressive Multiple Sclerosis

-Reuters

Reuters · -